Igc pharma welcomes industry leaders to advisory board, supporting alzheimer's innovation and ai-driven programs

Industry veterans bring deep strategic experience to guide alzheimer's clinical expansion and commercial strategy potomac, maryland / access newswire / april 21, 2025 / igc pharma, inc. (nyse american:igc) ("igc pharma" or the "company") today announced the addition of frank zaccanelli, robert k. coughlin, and joseph mangan to its board of advisors.
IGC Ratings Summary
IGC Quant Ranking